19
Views
34
CrossRef citations to date
0
Altmetric
Original Article

A randomized double-blind comparative study of terbinafine and griseofulvin in tinea capitis

, , , , , , , & show all
Pages 167-169 | Received 31 Jan 1994, Accepted 31 Jan 1995, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yuin-Chew Chan & Sheila F Friedlander. (2004) Therapeutic options in the treatment of tinea capitis. Expert Opinion on Pharmacotherapy 5:2, pages 219-227.
Read now
A. K. Gupta & R. C. Summerbell. (2000) Tinea capitis. Medical Mycology 38:4, pages 255-287.
Read now
Hr Memißolu, S Erboz, S Akkaya, T Akan, Vl Aksungur, I Ünal & M Karakaß. (1999) Comparative study of the efficacy and tolerability of 4 weeks of terbinafine therapy with 8 weeks of griseofulvin therapy in children with tinea capitis. Journal of Dermatological Treatment 10:3, pages 189-193.
Read now
I. Hussain, F. Muzaffar, T. Rashid, T.J. Ahmad, M. Jahangir & T.S. Haroon. (1999) A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Medical Mycology 37:2, pages 97-99.
Read now

Articles from other publishers (29)

Takashi Mochizuki, Ryoji Tsuboi, Ken Iozumi, Sumiko Ishizaki, Tsuyoshi Ushigami, Yumi Ogawa, Takehiko Kaneko, Masaaki Kawai, Yuki Kitami, Masahiro Kusuhara, Takeshi Kono, Toshiki Sato, Tomotaka Sato, Harunari Shimoyama, Motoi Takenaka, Hiroshi Tanabe, Gaku Tsuji, Yuichiro Tsunemi, Yasuki Hata, Kazutoshi Harada, Tomoo Fukuda, Tetsuo Matsuda & Ryuji Maruyama. (2020) Guidelines for the management of dermatomycosis (2019). The Journal of Dermatology 47:12, pages 1343-1373.
Crossref
Suthep Jerasutus, Voraphol Vejjabhinanta & Ornicha Prapapan. (2020) Treatment of tinea capitis with topical 1% encapsulated terbinafine hydrochloride gel: A pilot study. Pediatric Dermatology 37:6, pages 1090-1093.
Crossref
Jonathan Bar, Liat Samuelov, Eli Sprecher & Jacob Mashiah. (2019) Griseofulvin vs terbinafine for paediatric tinea capitis: When and for how long. Mycoses 62:10, pages 949-953.
Crossref
Amena Alkeswani, Wendy Cantrell & Boni Elewski. (2019) Treatment of Tinea Capitis. Skin Appendage Disorders 5:4, pages 201-210.
Crossref
Xiaomei Chen, Xia Jiang, Ming Yang, Cathy Bennett, Urbà González, Xiufang Lin, Xia Hua, Siliang Xue & Min Zhang. (2017) Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review. Journal of the American Academy of Dermatology 76:2, pages 368-374.
Crossref
Xiaomei Chen, Xia Jiang, Ming Yang, Urbà González, Xiufang Lin, Xia Hua, Siliang Xue, Min Zhang & Cathy Bennett. (2016) Systemic antifungal therapy for tinea capitis in children. Cochrane Database of Systematic Reviews 2016:5.
Crossref
Aditya K. Gupta & Chris Drummond‐Main. (2012) Meta‐Analysis of Randomized, Controlled Trials Comparing Particular Doses of Griseofulvin and Terbinafine for the Treatment of Tinea Capitis. Pediatric Dermatology 30:1, pages 1-6.
Crossref
Urbà González, Terry Seaton, George Bergus, Jim Jacobson & Cecilia Martínez‐Monzón. (2011) Cochrane Review: Systemic antifungal therapy for tinea capitis in children. Evidence-Based Child Health: A Cochrane Review Journal 6:5, pages 1697-1771.
Crossref
Hong Liang Tey, Andy Soon Leong Tan & Yuin Chew Chan. (2011) Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. Journal of the American Academy of Dermatology 64:4, pages 663-670.
Crossref
. 2011. British Association of Dermatologists' Management Guidelines. British Association of Dermatologists' Management Guidelines 91 117 .
Urbà González, Terry Seaton, George Bergus, Jim Jacobson & Cecilia Martínez‐Monzón. (2009) Cochrane review: Systemic antifungal therapy for tinea capitis in children. Evidence-Based Child Health: A Cochrane Review Journal 4:1, pages 132-221.
Crossref
Boni E. Elewski, Hector W. Cáceres, Liberation DeLeon, Saleh El Shimy, Judy A. Hunter, Nicolay Korotkiy, Ingrid Johnson Rachesky, Victoria Sanchez-Bal, Gail Todd, LindaAnn Wraith, Bin Cai, Amir Tavakkol, Rajesh Bakshi, Judit Nyirady & Sheila Fallon Friedlander. (2008) Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials∗. Journal of the American Academy of Dermatology 59:1, pages 41-54.
Crossref
Bryan K. Chen & Sheila Fallon Friedlander. 2008. Hair and Scalp Diseases. Hair and Scalp Diseases 277 295 .
Urbà González, Terry Seaton, George Bergus, Jim Jacobson & Cecilia Martínez-Monzón. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Brandie J Roberts & Sheila Fallon FriedIander. (2005) Tinea Capitis: A Treatment Update. Pediatric Annals 34:3, pages 191-200.
Crossref
David Fleece, John P. Gaughan & Stephen C. Aronoff. (2004) Griseofulvin Versus Terbinafine in the Treatment of Tinea Capitis: A Meta-analysis of Randomized, Clinical Trials. Pediatrics 114:5, pages 1312-1315.
Crossref
Yuin-Chew Chan & Sheila Fallon Friedlander. (2004) New treatments for tinea capitis. Current Opinion in Infectious Diseases 17:2, pages 97-103.
Crossref
D Devliotou-Panagiotidou & TH Koussidou-Eremondi. (2004) Efficacy and tolerability of 8 weeks' treatment with terbinafine in children with tinea capitis caused by Microsporum canis: a comparison of three doses. Journal of the European Academy of Dermatology and Venereology 18:2, pages 155-159.
Crossref
Michael Bigby. (2003) Newer antifungal agents. Journal of the American Academy of Dermatology 49:2, pages 357.
Crossref
H Silm & M Karelson. (2002) Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis . Journal of the European Academy of Dermatology and Venereology 16:3, pages 228-230.
Crossref
Aditya K. Gupta, Paul Adam, Ncoza Dlova, Charles W. Lynde, Sophie Hofstader, Nilesh Morar, Jamila Aboobaker & Richard C. Summerbell. (2008) Therapeutic Options for the Treatment of Tinea Capitis Caused by Trichophyton Species: Griseofulvin Versus the New Oral Antifungal Agents, Terbinafine, Itraconazole, and Fluconazole . Pediatric Dermatology 18:5, pages 433-438.
Crossref
L.C. Fuller, C.H. Smith, R. Cerio, R.A. Marsden, G. Midgley, A.L. Beard, E.M. Higgins & R.J. Hay. (2001) A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. British Journal of Dermatology 144:2, pages 321-327.
Crossref
E.M. Higgins, L.C. Fuller & C.H. Smith. (2000) Guidelines for the management of tinea capitis. British Journal of Dermatology 143:1, pages 53-58.
Crossref
Aditya K. GuptaSophie L. R. HofstaderPaul AdamRichard C. Summerbell. (2002) Tinea Capitis: An Overview with Emphasis on Management. Pediatric Dermatology 16:3, pages 171-189.
Crossref
I. Hussain, F. Muzaffar, T. Rashid, T. J. Ahmad, M. Jahangir & T. S. Haroon. (2008) A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Medical Mycology 37:2, pages 97-99.
Crossref
A. Wilmer & U. Wollina. (1998) Systemische Terbinafin-Therapie von Dermatophytosen im Kindesalter. Mycoses 41, pages 54-57.
Crossref
Jahangir, Hussain, UL Hasan & Haroon. (1998) A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. British Journal of Dermatology 139:4, pages 672-674.
Crossref
T.S. HAROON, I. HUSSAIN, S. AMAN, M. JAHANGIR, A.H. KAZMI, A.R. SAMI, A.H. NAGI, K.H. ALVI, N. IQBAL, K.A. KHAN & R. AZIZ. (1996) A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. British Journal of Dermatology 135:1, pages 86-88.
Crossref
T.S. HAROON, I. HUSSAIN, S. AMAN, M. JAHANGIR, A.H. KAZMI, A.R. SAMI, A.H. NAGI, K.H. ALVI, N. IQBAL, K.A. KHAN & R. AZIZ. (1996) A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. British Journal of Dermatology 135:1, pages 86-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.